Leukeran Oral Tablet 2Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Leukeran: Oral tablet (2mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_15455.JPG
Leukeran 2mg Tab
Aspen Global Inc
Pill Identification: GX EG3  |  L

What is this Medicine?

CHLORAMBUCIL (clor AM byoo sil) is a chemotherapy drug. It slows the growth of cancer cells. This medicine is used to treat cancer like some leukemias and lymphomas.

CVS Pharmacy Patient Statistics for Leukeran: Oral tablet(2mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Leukeran 2mg Tablet

NDC: 763880635
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Non-Hodgkin's Lymphoma (NHL), Hodgkin's Disease, Chronic Lymphocytic Leukemia (CLL)

Sometimes used for but not FDA approved for the following conditions:
Behcet's Syndrome, Systemic Lupus Erythematosus (SLE), Pneumonitis, Uveitis, Rheumatoid Arthritis, Nephrotic Syndrome, Polymyositis, Idiopathic Thrombocytopenic Purpura (ITP), Lupus Nephritis, Dermatomyositis, Wegener's Granulomatosis, Macroglobulinemia, Polyarteritis Nodosa, Churg-Strauss Syndrome

Storage Information
Store between 36 to 46 degrees F
Leukeran 2mg Tablet
Drug Image file DrugItem_15455.JPG
Aspen Global Inc
Pill Identification: GX EG3  |  L
Shape: round
Color: brown

Reported Side Effects for Leukeran 2mg Tablet

Lyell'S Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Skin Rash Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Paresis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Rapid Muscle Twitches Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Hallucinations Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Confusion Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Incoordination Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Convulsions Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Distressed Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Erythema Multiforme Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Shaking Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Mouth Sores Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Leukeran

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5